Iris Cheong
About Iris Cheong
Iris Cheong is the Controller at Dyno Therapeutics with over 15 years of experience in finance and accounting, particularly in the biotechnology and pharmaceutical industries.
Title and Current Role
Iris Cheong serves as the Controller at Dyno Therapeutics. Her role involves overseeing financial reporting and ensuring compliance with regulatory standards. She plays a critical part in the strategic financial planning and management for the biotechnology firm.
Past Professional Experience
Prior to joining Dyno Therapeutics, Iris Cheong held several significant roles in the finance and accounting sector. She has experience as the Director at Browne Consulting Group, Director of Finance at Omega Therapeutics, and Associate Director of Finance at Aegerion Pharmaceuticals. Her career began at KPMG, where she moved from a Senior Tax Associate to Audit Senior Manager, showcasing her versatility in both tax and audit functions.
Education and Certified Public Accountant
Iris Cheong holds a Bachelor's degree in Accounting and Finance from the University of Washington. She is also a certified public accountant, which underlines her expertise and professional credibility in the field of accounting and finance.
Experience in Biotechnology and Pharmaceuticals
Iris Cheong has extensive experience in the biotechnology and pharmaceutical industries. She has worked with notable companies such as Omega Therapeutics and Aegerion Pharmaceuticals. This background has equipped her with specialized knowledge and skills pertinent to the financial needs of life sciences firms.
Role at Browne Consulting Group
As Director at Browne Consulting Group, Iris Cheong led a team of eight professionals, providing operational accounting services to life science clients. Her role was significant in offering strategic accounting solutions and guiding the team to meet the specific needs of clients in the biotechnology sector.
Professional Network in Cambridge, Massachusetts
Iris Cheong has built a strong professional network in Cambridge, Massachusetts, through her roles at various companies in the region. This network has been instrumental in her career, facilitating collaborations and opportunities within the biotechnology hub.